Leica Biosystems Receives FDA 510(k) Clearance to Market a Digital Pathology System for Primary Diagnosis

VISTA, Calif., May 29, 2019 /PRNewswire/ -- Leica Biosystems, the global leader in pathology workflow solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX System for clinical diagnosis in the U.S. A multi-center...

from PR Newswire: https://prn.to/2YQGLMf